Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Garren

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Neurology|January 7, 2012
Evolution of MS lesions to black holes under DNA vaccine treatmentAthina Papadopoulou, Stefanie von Felten, Stefan Traud, et al.
Human Brain Mapping|January 17, 2019
Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosisJonathan O'Muircheartaigh, Irene Vavasour, Emil Ljungberg, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
Journal of Neurology|March 2, 2019
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosisBenjamin Turner, Bruce A C Cree, Ludwig Kappos, et al.
Neuroimage. Clinical|July 25, 2022
Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1aShannon Kolind, Shawna Abel, Carolyn Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Multiple elements of the allergic arm of the immune response modulate autoimmune demyelinationRosetta Pedotti, Jason J DeVoss, Sawsan Youssef, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitisPaulo Fontoura, Peggy P Ho, Jason DeVoss, et al.
The Lancet. Neurology|April 26, 2020
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAnthony Traboulsee, Benjamin M Greenberg, Jeffrey L Bennett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sitesNanette Solvason, Ya-Ping Lou, Wendy Peters, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 31, 2019
Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1aErin L MacMillan, Julia J Schubert, Irene M Vavasour, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Neurology|January 7, 2012
Evolution of MS lesions to black holes under DNA vaccine treatmentAthina Papadopoulou, Stefanie von Felten, Stefan Traud, et al.
Human Brain Mapping|January 17, 2019
Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosisJonathan O'Muircheartaigh, Irene Vavasour, Emil Ljungberg, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
Journal of Neurology|March 2, 2019
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosisBenjamin Turner, Bruce A C Cree, Ludwig Kappos, et al.
Neuroimage. Clinical|July 25, 2022
Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1aShannon Kolind, Shawna Abel, Carolyn Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Multiple elements of the allergic arm of the immune response modulate autoimmune demyelinationRosetta Pedotti, Jason J DeVoss, Sawsan Youssef, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitisPaulo Fontoura, Peggy P Ho, Jason DeVoss, et al.
The Lancet. Neurology|April 26, 2020
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAnthony Traboulsee, Benjamin M Greenberg, Jeffrey L Bennett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sitesNanette Solvason, Ya-Ping Lou, Wendy Peters, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 31, 2019
Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1aErin L MacMillan, Julia J Schubert, Irene M Vavasour, et al.
Pageof 4